Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,974 | -110,211 | -85,338 | -55,799 | -29,868 |
| Depreciation Amortization | 793 | 4,190 | 3,274 | 2,219 | 1,125 |
| Accounts receivable | 515 | -1,028 | 117 | 168 | 164 |
| Accounts payable and accrued liabilities | -905 | -995 | -1,887 | -317 | -851 |
| Other Working Capital | -2,463 | -4,821 | -6,956 | -2,935 | -2,058 |
| Other Operating Activity | 3,763 | 18,405 | 16,762 | 7,705 | 4,486 |
| Operating Cash Flow | $-24,271 | $-94,460 | $-74,028 | $-48,959 | $-27,002 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,889 | -97,400 | -90,706 | -102,392 | -129,341 |
| PPE Investments | -782 | -407 | -372 | -328 | -234 |
| Investing Cash Flow | $29,107 | $-97,807 | $-91,078 | $-102,720 | $-129,575 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -387 | -1,443 | -1,068 | -706 | -353 |
| Common Stock Issued | 249 | 38,109 | 1,055 | 276 | 52 |
| Common Stock Repurchased | -873 | -285 | -285 | -285 | -285 |
| Other Financing Activity | 0 | 0 | -146 | -136 | -136 |
| Financing Cash Flow | $-1,011 | $36,381 | $-444 | $-851 | $-722 |
| Beginning Cash Position | 30,423 | 186,309 | 186,309 | 186,309 | 186,309 |
| End Cash Position | 34,248 | 30,423 | 20,759 | 33,779 | 29,010 |
| Net Cash Flow | $3,825 | $-155,886 | $-165,550 | $-152,530 | $-157,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,271 | -94,460 | -74,028 | -48,959 | -27,002 |
| Capital Expenditure | -839 | -492 | -379 | -329 | -234 |
| Free Cash Flow | -25,110 | -94,952 | -74,407 | -49,288 | -27,236 |